Everyday Health Given New $18.00 Price Target at JPMorgan Chase & Co. (EVDY)
Equities research analysts at JPMorgan Chase & Co. increased their price target on shares of Everyday Health (NASDAQ:EVDY) from $16.00 to $18.00 in a research note issued to investors on Tuesday. JPMorgan Chase & Co.’s price target would indicate a potential upside of 6.38% from the company’s current price.
EVDY has been the subject of a number of other recent research reports. Analysts at Stifel Nicolaus raised their price target on shares of Everyday Health from $18.00 to $22.00 in a research note on Monday, June 23rd. They now have a “buy” rating on the stock. Separately, analysts at SunTrust reiterated a “buy” rating on shares of Everyday Health in a research note on Friday, May 16th. They now have a $20.00 price target on the stock. Four equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $20.20.
Everyday Health (NASDAQ:EVDY) opened at 16.92 on Tuesday. Everyday Health has a 52 week low of $11.84 and a 52 week high of $19.89. The stock’s 50-day moving average is $17.43 and its 200-day moving average is $16.07. The company’s market cap is $509.1 million.
Everyday Health (NASDAQ:EVDY) last posted its quarterly earnings results on Monday, August 11th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.06 by $0.01. The company had revenue of $41.40 million for the quarter, compared to the consensus estimate of $40.76 million. The company’s quarterly revenue was up 11.3% on a year-over-year basis. Analysts expect that Everyday Health will post $0.41 EPS for the current fiscal year.
Everyday Health, Inc is a provider of digital health and wellness solutions. The Company provides consumers and healthcare professionals with a multi-brand, multi-channel content experience that can be accessed anytime and anywhere a health-related decision is made.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.